South Africa and United Arab Emirates. As a first step, it is proposed to focus on the development of biologics markets and accelerating the entry of biosimilars into the BRICS markets. All the news ...

Emirates Biotech, a prominent player in the UAE's growing biotechnology sector, has announced plans to construct what is ...

Saudi venture capital firm KBW Ventures said it sees massive investment opportunities in China particularly in biotechnology and healthcare as busin ...

Orbia Advance Corporation S.A.B. de C.V.’s Fluor & Energy Materials business announced its readiness to advance construction ...

Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the countr | The Vertex agreement is part of ...

The large-scale polylactic acid production plans are expected to support regional and global efforts to combat plastic ...

Emirates Biotech has selected Sulzer’s technology for its upcoming Polylactic Acid production plant in the United Arab ...

Sulzer Ltd. (Winterthur, Switzerland) announced that its technology has been selected by Emirates Biotech for its upcoming ...

Shares of Agios Pharmaceuticals AGIO lost 21% yesterday after management revealed that two thalassemia patients who received ...

Emirates Biotech has selected Sulzer as the technology provider for its upcoming Polylactic Acid (PLA) production plant in the United Arab Emirates. The facility will be constructed in two phases, ...

The facility will be constructed in two phases, each with an annual capacity of 80,000 tonnes, resulting in a total ...

Cryptocurrency, particularly Bitcoin, is increasingly seen as a disruptive force across global financial systems, with a ...